Dr. William Michael Brode Dr. Esther Melamed Dr. Monica Verduzco-Gutierrez As the research on Long-COVID (PASC) is evolving at an excitingly rapid pace, this page of FAQs is reflective of information known as of February 2nd, 2023. 1. What are the symptoms of Long-COVID? (Dr. Esther Melamed) About 10% to 30% of patients who experienced severe or mild symptoms of COVID-19 develop Long-COVID syndrome (aka post-acute sequelae of SARS-CoV-2 infection (PASC)). The persistent symptoms of fatigue, brain fog, weakness, heart palpitations, vision changes, headaches, tinnitus, pain, sleep …
New Frontiers in COVID-19 and Autoimmunity
Written by: Chumeng Wang Edited by: Esther Melamed Since the beginning of the COVID-19 pandemic, researchers and clinicians have sought to determine predispositions that may put individuals at higher risk for severe disease. As the virus spread and information became available about typical recovery times, more questions arose as some patients reported symptoms of Long COVID, or Post-acute sequelae of COVID-19 (PASC), in which symptoms like fatigue, headache, and smell/taste changes can persist for weeks-months after initial infection not only in those who had been hospitalized, but also …
Long COVID: The Newest Post-Viral Syndrome
Written by: Parker Davis Edited by: Esther Melamed Post-viral syndromes have been well-documented for many prominent human viruses, including Influenza B virus (as far back as 1959), the coronaviruses that cause MERS and SARS, and coxsackieviruses, the agent that causes hand-foot-and-mouth disease (Adams, 1959; Calder et al., 1987). Though the symptoms are well characterized, the molecular and physiological processes that underlie post-viral syndromes are relatively poorly understood, as is the case with the post-COVID syndrome due to SARS-CoV-2 viral infection, also called “Long COVID” or …